Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Bought deal - placement
View:
Post by themagicbox on Feb 17, 2021 11:46pm

Bought deal - placement

Did anyone get in on the placement? Closed at 6:30 today. Not a bad deal for the free warrants.

Underwriters will likely keep the price above $6 till the BD closes on the 24th for those that are concened about a plummet. Usually its the penny flippers that care about the day to day.

The big money knows understands the value, and likely got in on the placement. We'll get to see the PH3 with free warrants. Like I said before, look at this month to month and I am sure you'll be very pleased. This will be frustrating for some, but the bigger picture is what matters and we know what we own.
Comment by TriumphSpitSix on Feb 17, 2021 11:53pm
I don't see this as bad news. For $12, an investor gets 2 shares and 1 warrant, which they will pay $7.50 to exercise for 1 more share. So that's 3 shares at $19.50 total or $6.50/each, just a ~7% difference from where we closed today. AND they're cashed up so in a much stronger negotiating position going forward. All good as far as I'm concerned.
Comment by MrMugsy on Feb 18, 2021 12:12am
Right Triumph ... not a bad price for cashing up.
Comment by crow27 on Feb 18, 2021 12:29am
So they receive  $35,100,000 up front plus if the warrants are exercised then they get another 21,937,500. So basically ATB can collect $57,037,500 with this deal.
Comment by crow27 on Feb 18, 2021 8:43am
If they also fill the 15% 30 day option then with cash and options exercised this  will put aprox 66 million in the pockets of ATB from this deal alone. So with existing cash (15 million) + Nuance up front payment (20 million) + this deal (66 million) = 100 million in the pockets of ATB. We are cashed up folks!!!
Comment by TheCanuckTrader on Feb 18, 2021 9:03am
Anyone know who the other underwriters are?
Comment by themagicbox on Feb 18, 2021 9:14am
Canaccord and bloom burton
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse